TOFATUNE-5
General Range

TOFATUNE-5

Fortune LabsPanchkula, Haryana

Price on request/100 · MOQ 100 boxes

TOFATUNE-5 Tablets by Fortune Labs contain Tofacitinib 5 mg, a prescription Janus Kinase (JAK) inhibitor used to manage selected autoimmune and inflammatory conditions. Tofacitinib helps regulate immune system activity and reduce inflammation in patients with conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis, where approved and clinically appropriate. TOFATUNE-5 is part of Fortune Labs' pharmaceutical product portfolio for authorized distributors and PCD Pharma Franchise partners across India. Contact Fortune Labs for product availability, wholesale pricing, distribution opportunities, and franchise enquiries. This medicine requires specialist supervision because of serious risks, including infections, blood clots, cardiovascular events, and malignancies. It should be used strictly according to approved prescribing guidelines.

CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Tofacitinib 5 mg
Packaging Type
Blister Pack
Packaging Size
10 × 10
Dosage Form
Tablet
Treatment
Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Ulcerative Colitis in eligible patients under specialist supervision.
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Fortune LabsPanchkula, Haryana
View Full Profile

Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.

Key Details

• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.

Product Portfolio & Therapeutic Ranges

• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?

More General Range

WhatsApp us